This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Morgan Ledford Vice President, Talent Management, OmnicellOmnicell is looking for the best and brightest this summer with internship opportunities across North America. As the Omnicell interns have shown, we care about developing and growing talent. Q: Why should someone consider an internship at Omnicell?
In a manual for hemophilia treatment centers, the agency states it is concerned that providers would have no reason to participate in 340B if insurers take the benefit of 340B savings from them. Disclaimer The views and opinions expressed in this blog are those of the authors. Subscribe today.
Kristen Dowd Director, Pharmacy Management Services, Omnicell If the 2022 NASP (National Association of Specialty Pharmacy) Annual Meeting and Expo is any indication, we are approaching a time when specialty pharmacy simply becomes pharmacy – when complex, high-touch biologics become nearly as ubiquitous as their broad-spectrum counterparts.
James Stevenson Chief Clinical Officer, Omnicell Since the beginning of COVID-19, healthcare employment has fallen by 524,000 jobs , resulting in a nationwide shortage of nurses, technicians, and more. A physician shortage is another looming issue. For years, the United States has been predicting a physician shortage.
More and more commercial insurers are insisting on contract terms that require covered entities to accept reimbursement rates that can be significantly below the rates offered to non-340B providers and pharmacies, resulting in an indirect transfer of 340B savings from the covered entities to the insurance companies and pharmacy benefit managers.
The bill, which already has 74 co-sponsors, would also prohibit commercial insurers and PBMs from imposing contract terms that require covered entities to accept reimbursement rates that can be significantly below the rates offered to non-340B providers and pharmacies. 340B providers need to begin a full-court press today.
On the one hand, the bill includes important consumer and provider-friendly wins such as the extension of Affordable Care Act insurance subsidies for lower to middle-income Americans that were set to expire later this year. Disclaimer The views and opinions expressed in this blog are those of the authors. Subscribe today.
ʼ ” The DOJ added, “the providers, in turn, can generate much-needed revenue through sale of those medications (particularly to patients who are insured) or pass along the discounts directly to patients. The 340B Program has served a crucial role in facilitating healthcare for vulnerable patients ever since.
Health Insurance The EO directs HHS to standardize options in the National Health Insurance Marketplace (HealthCare.gov) so that people can comparison shop more easily. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell How much health policy change can the Biden administration effect during the next four years? Which way will the political winds blow in Washington, D.C.? Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).
University of Pennsylvania law professor Allison Hoffman argued in a blog post just before the hearing that “even if the Court decides against CMS and strikes down the rule, the most the 340B providers would get is retroactive payments for the two years at issue in the case.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content